What are you prescribing for atrial fibrillation?

Dr Aajuli Shukla

writer

Dr Aajuli Shukla

General Practitioner; Deputy Medical Editor, Medical Journal of Australia; Member of the Editorial Advisory Board for the Diabetes Management Journal

Dr Aajuli Shukla

 

Despite the widespread uptake of DOACs, they are still underutilised and atrial fibrillation is still undertreated in Australia.

This is according to Dr Andrew Sindone, Cardiologist and Director of the Heart Failure Unit and Department of Cardiac Rehabilitation at Concord Hospital, New South Wales.

“The general practitioner is the gatekeeper. They are often the ones who detect it [atrial fibrillation], or suspect it, and either treat it or refer on.”

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

1 Figure 1 of the paper. https://doi.org/10.1016/j.hlc.2018.03.010

2 “Australians with non-valvular atrial fibrillation are currently using NOACs in preference to warfarin at a ratio of 2:1.”
https://doi.org/10.1016/j.hlc.2018.03.010

3 In this nationwide cohort study of patients ≥75 years initiating oral anticoagulation for AF, standard and reduced dose NOACs were associated with similar risks of stroke/SE as warfarin and lower or similar risks of bleeding. The NOACs seem to be a safe option also in elderly patients. https://heart.bmj.com/content/108/5/345

4 The use of DOACs is a reasonable alternative to vitamin K antagonists in AF patients with CHADS2 score ≥3, advanced age, and HF. The RI constitutes a useful, additional tool to facilitate clinicians in choosing DOACs or warfarin in particular category of AF patients. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761253/

5 “Warfarin was associated with a greater decline in eGFR than either low-dose (HR: 0.81, 95% CI: 0.69–0.96) or standard-dose dabigatran (HR: 0.79, 95% CI: 0.68–0.93), whereas apixaban showed a similar risk of acute renal failure compared with warfarin in ARISTOTLE trial (RR: 0.97, 95% CI: 0.88–1.07)” https://journals.lww.com/md-journal/Fulltext/2019/11290/The_impact_of_renal_function_on_efficacy_and.87.aspx

6 However, mechanical heart valves currently pose an absolute contraindication to NOACs based on the results of a single phase II study comparing dabigatran and warfarin (RE-ALIGN [Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement]). That trial was stopped prematurely because of an excess of both stroke and bleeding with the dabigatran doses tested https://doi.org/10.1161/CIRCULATIONAHA.118.035612

7 Individual state government sites and also this article from RACGP https://www.racgp.org.au/afp/2014/may/anticoagulation

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Acutely Painful Shoulder – Assessment and Management in GP

Dr Richard Phoon

Dr Richard Phoon

Chronic Kidney Disease – Delay Progression and Prevent Dialysis

Prof Rodney Baber AM

Prof Rodney Baber AM

Understand & Explain the Risks & Side Effects of MHT

Prof Peter Richmond

Prof Peter Richmond

Invasive Pneumococcal Disease – What GPs Need to Know

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Aajuli Shukla

writer

Dr Aajuli Shukla

General Practitioner; Deputy Medical Editor, Medical Journal of Australia; Member of the Editorial Advisory Board for the Diabetes Management Journal

Test your knowledge

Recent articles

Latest GP poll

With regard to child & adolescent mental health issues you encounter in your practice, to what extent do you think overuse of digital devices and social media is a contributing factor?

A major contributor

0%

A moderate contributor

0%

A minor contributor

0%

Not a contributor

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Tuesday 14th October, 7pm - 9pm AEDT

Speaker

Dr Sushil Pant

Orthopaedic Surgeon; Sydney Sports Medicine Centre

We invite you to our next free webcast, where Dr Sushil Pant will present on acutely painful shoulder. Up to 4 hours CPD. RACGP & ACRRM accredited.